Month: December 2020

This week, we offer thoughts on the end of the no-deal Brexit threat, the enactment of a U.S. stimulus and appropriation package, and a brief update on vaccines (and hope) for 2021.

This week we provide our thoughts on the pandemic relief bill, a new-found COVID-19 strain in the U.K., and the approval of a second COVID-19 vaccine in the U.S.

This week we provide our thoughts on the emergency use authorization of a COVID-19 vaccine, the potential for a net upgrade in 2021 for the U.S. credit market, last-minute Brexit trade deal attempts, and the largest acquisition in the pharmaceutical industry for 2020.

This week we provide our thoughts on ongoing stimulus negotiations, implications of a no-deal Brexit, and stalled EU budget plans.